Gefitinib: A Targeted Therapy for Lung Cancer
Publié : 25 mars 2025 07:14
Gefitinib is a tyrosine kinase inhibitor (TKI) used primarily for the treatment of non-small cell lung cancer (NSCLC). It works by blocking the epidermal growth factor receptor (EGFR), which plays a crucial role in the growth and spread of cancer cells. Gefitinib is particularly effective in patients with EGFR mutations, helping to slow tumor progression and improve survival rates.
This oral medication is prescribed as a once-daily tablet, offering a convenient treatment option for patients. It is generally well-tolerated, though some may experience side effects such as diarrhea, rash, and nausea. Regular monitoring by healthcare professionals ensures optimal results while managing potential adverse effects.
As a life-saving drug in oncology, Gefitinib is widely manufactured by pharmaceutical companies worldwide. If you are looking for a Gefitinib tablet manufacturer in India, numerous reliable suppliers produce high-quality formulations that meet international standards. Indian manufacturers play a key role in making this targeted therapy more accessible and affordable for patients globally.
With ongoing advancements in cancer treatment, Gefitinib continues to be a preferred option for personalized lung cancer therapy. Its ability to target specific cancer cells makes it a crucial part of precision medicine in oncology.
This oral medication is prescribed as a once-daily tablet, offering a convenient treatment option for patients. It is generally well-tolerated, though some may experience side effects such as diarrhea, rash, and nausea. Regular monitoring by healthcare professionals ensures optimal results while managing potential adverse effects.
As a life-saving drug in oncology, Gefitinib is widely manufactured by pharmaceutical companies worldwide. If you are looking for a Gefitinib tablet manufacturer in India, numerous reliable suppliers produce high-quality formulations that meet international standards. Indian manufacturers play a key role in making this targeted therapy more accessible and affordable for patients globally.
With ongoing advancements in cancer treatment, Gefitinib continues to be a preferred option for personalized lung cancer therapy. Its ability to target specific cancer cells makes it a crucial part of precision medicine in oncology.